SidaSubSaharaV1, PascalFrancis, Corpus, bibRecord, 000463

Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study

Identifieur interne : 000463 ( PascalFrancis/Corpus ); précédent : 000462; suivant : 000464

Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study

Auteurs : Laura K. Murray ; Katherine Semrau ; Ellen Mccurley ; Donald M. Thea ; Nancy Scott ; Mwiya Mwiya ; Chipepo Kankasa ; Judith Bass ; Paul Bolton

Source :

AIDS Care : (Print) [ 0954-0121 ] ; 2009.

RBID : Pascal:09-0176016

Descripteurs français

Pascal (Inist)
- Observance médicamenteuse, Pharmacothérapie, Antirétroviral, Milieu urbain, Analyse qualitative, SIDA, Santé publique, Zambie, Facteur prédictif, Prise de décision, Homme, Femme, Antiviral, Acceptabilité.

English descriptors

KwdEn :
- AIDS, Antiretroviral agent, Antiviral, Decision making, Drug compliance, Human, Pharmacotherapy, Predictive factor, Public health, Qualitative analysis, Urban environment, Woman, Zambia.

Abstract

Sub-Saharan Africa contains over 60% of the world's HIV infections and Zambia is among the most severely affected countries in the region. As antiretroviral programs have been rapidly expanding, the long-term success of these programs depends on a good understanding of the behavioral determinants of acceptance and adherence to antiretroviral therapy (ART). The study used qualitative methods to gain local insight into potentially important factors affecting HIV-infected women's decision to accept or continue with ART. Some of the barriers identified by this study are consistent with factors cited in the existing adherence literature from both developed and developing nations such as side effects, hunger and stigma; other factors have not been previously reported. One major theme was unfamiliarity with the implications of having a chronic, potentially deadly disease. Other emerging themes from this study include the complicated effect of ART on interpersonal relationship, particularly between husbands and wives, the presence of depression and hopelessness, and lack of accurate information. The results suggest that the reasons for non-uptake of treatment include issues related to local cultural frameworks (e.g., illness ideology), mental and behavioral health (e.g., depression and/or interpersonal challenges), stigma, and motivating factors (e.g., values of church or marriage) of different cultures that affect the ability and willingness to take life-saving medicine for a long period of time. Qualitative studies are critical to better understand why ART eligible individuals are choosing not to initiate or continue treatment to achieve needed adherence levels.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0954-0121`
A03		`1`		`@0 AIDS Care : (Print)`
A05				`@2 21`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study`
A11	`01`	`1`		`@1 MURRAY (Laura K.)`
A11	`02`	`1`		`@1 SEMRAU (Katherine)`
A11	`03`	`1`		`@1 MCCURLEY (Ellen)`
A11	`04`	`1`		`@1 THEA (Donald M.)`
A11	`05`	`1`		`@1 SCOTT (Nancy)`
A11	`06`	`1`		`@1 MWIYA (Mwiya)`
A11	`07`	`1`		`@1 KANKASA (Chipepo)`
A11	`08`	`1`		`@1 BASS (Judith)`
A11	`09`	`1`		`@1 BOLTON (Paul)`
A14	`01`			`@1 Center for International Health and Development, Boston University School of Public Health @2 Boston @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut.`
A14	`02`			`@1 The Pendulam Project @3 INC @Z 3 aut.`
A14	`03`			`@1 University Teaching Hospital @2 Lusaka @3 ZMB @Z 6 aut. @Z 7 aut.`
A14	`04`			`@1 Johns Hopkins University, School of Public Health @2 Baltimore, MD @3 USA @Z 8 aut. @Z 9 aut.`
A20				`@1 78-86`
A21				`@1 2009`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 22096 @5 354000184082610110`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 1 p.1/4`
A47	`01`	`1`		`@0 09-0176016`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 AIDS Care : (Print)`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Sub-Saharan Africa contains over 60% of the world's HIV infections and Zambia is among the most severely affected countries in the region. As antiretroviral programs have been rapidly expanding, the long-term success of these programs depends on a good understanding of the behavioral determinants of acceptance and adherence to antiretroviral therapy (ART). The study used qualitative methods to gain local insight into potentially important factors affecting HIV-infected women's decision to accept or continue with ART. Some of the barriers identified by this study are consistent with factors cited in the existing adherence literature from both developed and developing nations such as side effects, hunger and stigma; other factors have not been previously reported. One major theme was unfamiliarity with the implications of having a chronic, potentially deadly disease. Other emerging themes from this study include the complicated effect of ART on interpersonal relationship, particularly between husbands and wives, the presence of depression and hopelessness, and lack of accurate information. The results suggest that the reasons for non-uptake of treatment include issues related to local cultural frameworks (e.g., illness ideology), mental and behavioral health (e.g., depression and/or interpersonal challenges), stigma, and motivating factors (e.g., values of church or marriage) of different cultures that affect the ability and willingness to take life-saving medicine for a long period of time. Qualitative studies are critical to better understand why ART eligible individuals are choosing not to initiate or continue treatment to achieve needed adherence levels.
C02	`01`	`X`		`@0 002B02S05`
C02	`02`	`X`		`@0 002A26N03A`
C03	`01`	`X`	`FRE`	`@0 Observance médicamenteuse @5 01`
C03	`01`	`X`	`ENG`	`@0 Drug compliance @5 01`
C03	`01`	`X`	`SPA`	`@0 Observancia de la medicación @5 01`
C03	`02`	`X`	`FRE`	`@0 Pharmacothérapie @5 02`
C03	`02`	`X`	`ENG`	`@0 Pharmacotherapy @5 02`
C03	`02`	`X`	`SPA`	`@0 Farmacoterapia @5 02`
C03	`03`	`X`	`FRE`	`@0 Antirétroviral @5 03`
C03	`03`	`X`	`ENG`	`@0 Antiretroviral agent @5 03`
C03	`03`	`X`	`SPA`	`@0 Antiretroviral @5 03`
C03	`04`	`X`	`FRE`	`@0 Milieu urbain @5 04`
C03	`04`	`X`	`ENG`	`@0 Urban environment @5 04`
C03	`04`	`X`	`SPA`	`@0 Medio urbano @5 04`
C03	`05`	`X`	`FRE`	`@0 Analyse qualitative @5 05`
C03	`05`	`X`	`ENG`	`@0 Qualitative analysis @5 05`
C03	`05`	`X`	`SPA`	`@0 Análisis cualitativo @5 05`
C03	`06`	`X`	`FRE`	`@0 SIDA @5 06`
C03	`06`	`X`	`ENG`	`@0 AIDS @5 06`
C03	`06`	`X`	`SPA`	`@0 SIDA @5 06`
C03	`07`	`X`	`FRE`	`@0 Santé publique @5 07`
C03	`07`	`X`	`ENG`	`@0 Public health @5 07`
C03	`07`	`X`	`SPA`	`@0 Salud pública @5 07`
C03	`08`	`X`	`FRE`	`@0 Zambie @2 NG @5 08`
C03	`08`	`X`	`ENG`	`@0 Zambia @2 NG @5 08`
C03	`08`	`X`	`SPA`	`@0 Zambia @2 NG @5 08`
C03	`09`	`X`	`FRE`	`@0 Facteur prédictif @5 09`
C03	`09`	`X`	`ENG`	`@0 Predictive factor @5 09`
C03	`09`	`X`	`SPA`	`@0 Factor predictivo @5 09`
C03	`10`	`X`	`FRE`	`@0 Prise de décision @5 10`
C03	`10`	`X`	`ENG`	`@0 Decision making @5 10`
C03	`10`	`X`	`SPA`	`@0 Toma decision @5 10`
C03	`11`	`X`	`FRE`	`@0 Homme @5 19`
C03	`11`	`X`	`ENG`	`@0 Human @5 19`
C03	`11`	`X`	`SPA`	`@0 Hombre @5 19`
C03	`12`	`X`	`FRE`	`@0 Femme @5 20`
C03	`12`	`X`	`ENG`	`@0 Woman @5 20`
C03	`12`	`X`	`SPA`	`@0 Mujer @5 20`
C03	`13`	`X`	`FRE`	`@0 Antiviral @5 31`
C03	`13`	`X`	`ENG`	`@0 Antiviral @5 31`
C03	`13`	`X`	`SPA`	`@0 Antiviral @5 31`
C03	`14`	`X`	`FRE`	`@0 Acceptabilité @4 INC @5 86`
C07	`01`	`X`	`FRE`	`@0 Traitement`
C07	`01`	`X`	`ENG`	`@0 Treatment`
C07	`01`	`X`	`SPA`	`@0 Tratamiento`
C07	`02`	`X`	`FRE`	`@0 Virose`
C07	`02`	`X`	`ENG`	`@0 Viral disease`
C07	`02`	`X`	`SPA`	`@0 Virosis`
C07	`03`	`X`	`FRE`	`@0 Infection`
C07	`03`	`X`	`ENG`	`@0 Infection`
C07	`03`	`X`	`SPA`	`@0 Infección`
C07	`04`	`X`	`FRE`	`@0 Afrique @2 NG`
C07	`04`	`X`	`ENG`	`@0 Africa @2 NG`
C07	`04`	`X`	`SPA`	`@0 Africa @2 NG`
C07	`05`	`X`	`FRE`	`@0 Environnement social @5 38`
C07	`05`	`X`	`ENG`	`@0 Social environment @5 38`
C07	`05`	`X`	`SPA`	`@0 Contexto social @5 38`
C07	`06`	`X`	`FRE`	`@0 Immunodéficit @5 39`
C07	`06`	`X`	`ENG`	`@0 Immune deficiency @5 39`
C07	`06`	`X`	`SPA`	`@0 Inmunodeficiencia @5 39`
C07	`07`	`X`	`FRE`	`@0 Immunopathologie @5 41`
C07	`07`	`X`	`ENG`	`@0 Immunopathology @5 41`
C07	`07`	`X`	`SPA`	`@0 Inmunopatología @5 41`
N21				`@1 131`

Format Inist (serveur)

NO :	PASCAL 09-0176016 INIST
ET :	Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study
AU :	MURRAY (Laura K.); SEMRAU (Katherine); MCCURLEY (Ellen); THEA (Donald M.); SCOTT (Nancy); MWIYA (Mwiya); KANKASA (Chipepo); BASS (Judith); BOLTON (Paul)
AF :	Center for International Health and Development, Boston University School of Public Health/Boston/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 5 aut.); The Pendulam Project/Inconnu (3 aut.); University Teaching Hospital/Lusaka/Zambie (6 aut., 7 aut.); Johns Hopkins University, School of Public Health/Baltimore, MD/Etats-Unis (8 aut., 9 aut.)
DT :	Publication en série; Niveau analytique
SO :	AIDS Care : (Print); ISSN 0954-0121; Royaume-Uni; Da. 2009; Vol. 21; No. 1; Pp. 78-86; Bibl. 1 p.1/4
LA :	Anglais
EA :	Sub-Saharan Africa contains over 60% of the world's HIV infections and Zambia is among the most severely affected countries in the region. As antiretroviral programs have been rapidly expanding, the long-term success of these programs depends on a good understanding of the behavioral determinants of acceptance and adherence to antiretroviral therapy (ART). The study used qualitative methods to gain local insight into potentially important factors affecting HIV-infected women's decision to accept or continue with ART. Some of the barriers identified by this study are consistent with factors cited in the existing adherence literature from both developed and developing nations such as side effects, hunger and stigma; other factors have not been previously reported. One major theme was unfamiliarity with the implications of having a chronic, potentially deadly disease. Other emerging themes from this study include the complicated effect of ART on interpersonal relationship, particularly between husbands and wives, the presence of depression and hopelessness, and lack of accurate information. The results suggest that the reasons for non-uptake of treatment include issues related to local cultural frameworks (e.g., illness ideology), mental and behavioral health (e.g., depression and/or interpersonal challenges), stigma, and motivating factors (e.g., values of church or marriage) of different cultures that affect the ability and willingness to take life-saving medicine for a long period of time. Qualitative studies are critical to better understand why ART eligible individuals are choosing not to initiate or continue treatment to achieve needed adherence levels.
CC :	002B02S05; 002A26N03A
FD :	Observance médicamenteuse; Pharmacothérapie; Antirétroviral; Milieu urbain; Analyse qualitative; SIDA; Santé publique; Zambie; Facteur prédictif; Prise de décision; Homme; Femme; Antiviral; Acceptabilité
FG :	Traitement; Virose; Infection; Afrique; Environnement social; Immunodéficit; Immunopathologie
ED :	Drug compliance; Pharmacotherapy; Antiretroviral agent; Urban environment; Qualitative analysis; AIDS; Public health; Zambia; Predictive factor; Decision making; Human; Woman; Antiviral
EG :	Treatment; Viral disease; Infection; Africa; Social environment; Immune deficiency; Immunopathology
SD :	Observancia de la medicación; Farmacoterapia; Antiretroviral; Medio urbano; Análisis cualitativo; SIDA; Salud pública; Zambia; Factor predictivo; Toma decision; Hombre; Mujer; Antiviral
LO :	INIST-22096.354000184082610110
ID :	09-0176016

Links to Exploration step

Pascal:09-0176016

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study</title>
<author><name sortKey="Murray, Laura K" sort="Murray, Laura K" uniqKey="Murray L" first="Laura K." last="Murray">Laura K. Murray</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Semrau, Katherine" sort="Semrau, Katherine" uniqKey="Semrau K" first="Katherine" last="Semrau">Katherine Semrau</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mccurley, Ellen" sort="Mccurley, Ellen" uniqKey="Mccurley E" first="Ellen" last="Mccurley">Ellen Mccurley</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>The Pendulam Project</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Thea, Donald M" sort="Thea, Donald M" uniqKey="Thea D" first="Donald M." last="Thea">Donald M. Thea</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Scott, Nancy" sort="Scott, Nancy" uniqKey="Scott N" first="Nancy" last="Scott">Nancy Scott</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mwiya, Mwiya" sort="Mwiya, Mwiya" uniqKey="Mwiya M" first="Mwiya" last="Mwiya">Mwiya Mwiya</name>
<affiliation><inist:fA14 i1="03"><s1>University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kankasa, Chipepo" sort="Kankasa, Chipepo" uniqKey="Kankasa C" first="Chipepo" last="Kankasa">Chipepo Kankasa</name>
<affiliation><inist:fA14 i1="03"><s1>University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bass, Judith" sort="Bass, Judith" uniqKey="Bass J" first="Judith" last="Bass">Judith Bass</name>
<affiliation><inist:fA14 i1="04"><s1>Johns Hopkins University, School of Public Health</s1>
<s2>Baltimore, MD</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bolton, Paul" sort="Bolton, Paul" uniqKey="Bolton P" first="Paul" last="Bolton">Paul Bolton</name>
<affiliation><inist:fA14 i1="04"><s1>Johns Hopkins University, School of Public Health</s1>
<s2>Baltimore, MD</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0176016</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0176016 INIST</idno>
<idno type="RBID">Pascal:09-0176016</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000463</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study</title>
<author><name sortKey="Murray, Laura K" sort="Murray, Laura K" uniqKey="Murray L" first="Laura K." last="Murray">Laura K. Murray</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Semrau, Katherine" sort="Semrau, Katherine" uniqKey="Semrau K" first="Katherine" last="Semrau">Katherine Semrau</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mccurley, Ellen" sort="Mccurley, Ellen" uniqKey="Mccurley E" first="Ellen" last="Mccurley">Ellen Mccurley</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>The Pendulam Project</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Thea, Donald M" sort="Thea, Donald M" uniqKey="Thea D" first="Donald M." last="Thea">Donald M. Thea</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Scott, Nancy" sort="Scott, Nancy" uniqKey="Scott N" first="Nancy" last="Scott">Nancy Scott</name>
<affiliation><inist:fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mwiya, Mwiya" sort="Mwiya, Mwiya" uniqKey="Mwiya M" first="Mwiya" last="Mwiya">Mwiya Mwiya</name>
<affiliation><inist:fA14 i1="03"><s1>University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kankasa, Chipepo" sort="Kankasa, Chipepo" uniqKey="Kankasa C" first="Chipepo" last="Kankasa">Chipepo Kankasa</name>
<affiliation><inist:fA14 i1="03"><s1>University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bass, Judith" sort="Bass, Judith" uniqKey="Bass J" first="Judith" last="Bass">Judith Bass</name>
<affiliation><inist:fA14 i1="04"><s1>Johns Hopkins University, School of Public Health</s1>
<s2>Baltimore, MD</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bolton, Paul" sort="Bolton, Paul" uniqKey="Bolton P" first="Paul" last="Bolton">Paul Bolton</name>
<affiliation><inist:fA14 i1="04"><s1>Johns Hopkins University, School of Public Health</s1>
<s2>Baltimore, MD</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">AIDS Care : (Print)</title>
<title level="j" type="abbreviated">AIDS Care : (Print)</title>
<idno type="ISSN">0954-0121</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">AIDS Care : (Print)</title>
<title level="j" type="abbreviated">AIDS Care : (Print)</title>
<idno type="ISSN">0954-0121</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Antiretroviral agent</term>
<term>Antiviral</term>
<term>Decision making</term>
<term>Drug compliance</term>
<term>Human</term>
<term>Pharmacotherapy</term>
<term>Predictive factor</term>
<term>Public health</term>
<term>Qualitative analysis</term>
<term>Urban environment</term>
<term>Woman</term>
<term>Zambia</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Observance médicamenteuse</term>
<term>Pharmacothérapie</term>
<term>Antirétroviral</term>
<term>Milieu urbain</term>
<term>Analyse qualitative</term>
<term>SIDA</term>
<term>Santé publique</term>
<term>Zambie</term>
<term>Facteur prédictif</term>
<term>Prise de décision</term>
<term>Homme</term>
<term>Femme</term>
<term>Antiviral</term>
<term>Acceptabilité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sub-Saharan Africa contains over 60% of the world's HIV infections and Zambia is among the most severely affected countries in the region. As antiretroviral programs have been rapidly expanding, the long-term success of these programs depends on a good understanding of the behavioral determinants of acceptance and adherence to antiretroviral therapy (ART). The study used qualitative methods to gain local insight into potentially important factors affecting HIV-infected women's decision to accept or continue with ART. Some of the barriers identified by this study are consistent with factors cited in the existing adherence literature from both developed and developing nations such as side effects, hunger and stigma; other factors have not been previously reported. One major theme was unfamiliarity with the implications of having a chronic, potentially deadly disease. Other emerging themes from this study include the complicated effect of ART on interpersonal relationship, particularly between husbands and wives, the presence of depression and hopelessness, and lack of accurate information. The results suggest that the reasons for non-uptake of treatment include issues related to local cultural frameworks (e.g., illness ideology), mental and behavioral health (e.g., depression and/or interpersonal challenges), stigma, and motivating factors (e.g., values of church or marriage) of different cultures that affect the ability and willingness to take life-saving medicine for a long period of time. Qualitative studies are critical to better understand why ART eligible individuals are choosing not to initiate or continue treatment to achieve needed adherence levels.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0954-0121</s0>
</fA01>
<fA03 i2="1"><s0>AIDS Care : (Print)</s0>
</fA03>
<fA05><s2>21</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MURRAY (Laura K.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SEMRAU (Katherine)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MCCURLEY (Ellen)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>THEA (Donald M.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SCOTT (Nancy)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>MWIYA (Mwiya)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KANKASA (Chipepo)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>BASS (Judith)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>BOLTON (Paul)</s1>
</fA11>
<fA14 i1="01"><s1>Center for International Health and Development, Boston University School of Public Health</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>The Pendulam Project</s1>
<s3>INC</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>University Teaching Hospital</s1>
<s2>Lusaka</s2>
<s3>ZMB</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Johns Hopkins University, School of Public Health</s1>
<s2>Baltimore, MD</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA20><s1>78-86</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>22096</s2>
<s5>354000184082610110</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>1 p.1/4</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0176016</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>AIDS Care : (Print)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Sub-Saharan Africa contains over 60% of the world's HIV infections and Zambia is among the most severely affected countries in the region. As antiretroviral programs have been rapidly expanding, the long-term success of these programs depends on a good understanding of the behavioral determinants of acceptance and adherence to antiretroviral therapy (ART). The study used qualitative methods to gain local insight into potentially important factors affecting HIV-infected women's decision to accept or continue with ART. Some of the barriers identified by this study are consistent with factors cited in the existing adherence literature from both developed and developing nations such as side effects, hunger and stigma; other factors have not been previously reported. One major theme was unfamiliarity with the implications of having a chronic, potentially deadly disease. Other emerging themes from this study include the complicated effect of ART on interpersonal relationship, particularly between husbands and wives, the presence of depression and hopelessness, and lack of accurate information. The results suggest that the reasons for non-uptake of treatment include issues related to local cultural frameworks (e.g., illness ideology), mental and behavioral health (e.g., depression and/or interpersonal challenges), stigma, and motivating factors (e.g., values of church or marriage) of different cultures that affect the ability and willingness to take life-saving medicine for a long period of time. Qualitative studies are critical to better understand why ART eligible individuals are choosing not to initiate or continue treatment to achieve needed adherence levels.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02S05</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002A26N03A</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Observance médicamenteuse</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Drug compliance</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Observancia de la medicación</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pharmacothérapie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Pharmacotherapy</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Farmacoterapia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Antirétroviral</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Antiretroviral agent</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Antiretroviral</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Milieu urbain</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Urban environment</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Medio urbano</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Analyse qualitative</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Qualitative analysis</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Análisis cualitativo</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>SIDA</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>AIDS</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>SIDA</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Public health</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Zambie</s0>
<s2>NG</s2>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Zambia</s0>
<s2>NG</s2>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Zambia</s0>
<s2>NG</s2>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Facteur prédictif</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Predictive factor</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Factor predictivo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Prise de décision</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Decision making</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Toma decision</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Homme</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Human</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Hombre</s0>
<s5>19</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Femme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Woman</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Mujer</s0>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Antiviral</s0>
<s5>31</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Antiviral</s0>
<s5>31</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Antiviral</s0>
<s5>31</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Acceptabilité</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Traitement</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Treatment</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Tratamiento</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Afrique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Environnement social</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Social environment</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Contexto social</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Immunodéficit</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Immune deficiency</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Inmunodeficiencia</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>131</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 09-0176016 INIST</NO>
<ET>Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study</ET>
<AU>MURRAY (Laura K.); SEMRAU (Katherine); MCCURLEY (Ellen); THEA (Donald M.); SCOTT (Nancy); MWIYA (Mwiya); KANKASA (Chipepo); BASS (Judith); BOLTON (Paul)</AU>
<AF>Center for International Health and Development, Boston University School of Public Health/Boston/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 5 aut.); The Pendulam Project/Inconnu (3 aut.); University Teaching Hospital/Lusaka/Zambie (6 aut., 7 aut.); Johns Hopkins University, School of Public Health/Baltimore, MD/Etats-Unis (8 aut., 9 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>AIDS Care : (Print); ISSN 0954-0121; Royaume-Uni; Da. 2009; Vol. 21; No. 1; Pp. 78-86; Bibl. 1 p.1/4</SO>
<LA>Anglais</LA>
<EA>Sub-Saharan Africa contains over 60% of the world's HIV infections and Zambia is among the most severely affected countries in the region. As antiretroviral programs have been rapidly expanding, the long-term success of these programs depends on a good understanding of the behavioral determinants of acceptance and adherence to antiretroviral therapy (ART). The study used qualitative methods to gain local insight into potentially important factors affecting HIV-infected women's decision to accept or continue with ART. Some of the barriers identified by this study are consistent with factors cited in the existing adherence literature from both developed and developing nations such as side effects, hunger and stigma; other factors have not been previously reported. One major theme was unfamiliarity with the implications of having a chronic, potentially deadly disease. Other emerging themes from this study include the complicated effect of ART on interpersonal relationship, particularly between husbands and wives, the presence of depression and hopelessness, and lack of accurate information. The results suggest that the reasons for non-uptake of treatment include issues related to local cultural frameworks (e.g., illness ideology), mental and behavioral health (e.g., depression and/or interpersonal challenges), stigma, and motivating factors (e.g., values of church or marriage) of different cultures that affect the ability and willingness to take life-saving medicine for a long period of time. Qualitative studies are critical to better understand why ART eligible individuals are choosing not to initiate or continue treatment to achieve needed adherence levels.</EA>
<CC>002B02S05; 002A26N03A</CC>
<FD>Observance médicamenteuse; Pharmacothérapie; Antirétroviral; Milieu urbain; Analyse qualitative; SIDA; Santé publique; Zambie; Facteur prédictif; Prise de décision; Homme; Femme; Antiviral; Acceptabilité</FD>
<FG>Traitement; Virose; Infection; Afrique; Environnement social; Immunodéficit; Immunopathologie</FG>
<ED>Drug compliance; Pharmacotherapy; Antiretroviral agent; Urban environment; Qualitative analysis; AIDS; Public health; Zambia; Predictive factor; Decision making; Human; Woman; Antiviral</ED>
<EG>Treatment; Viral disease; Infection; Africa; Social environment; Immune deficiency; Immunopathology</EG>
<SD>Observancia de la medicación; Farmacoterapia; Antiretroviral; Medio urbano; Análisis cualitativo; SIDA; Salud pública; Zambia; Factor predictivo; Toma decision; Hombre; Mujer; Antiviral</SD>
<LO>INIST-22096.354000184082610110</LO>
<ID>09-0176016</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000463 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000463 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0176016
   |texte=   Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study
}}

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024

	Le SIDA en Afrique subsaharienne (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA en Afrique subsaharienne (serveur d'exploration)

Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study

Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women : a qualitative study

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri